Lehigh Valley Health Network Selects StudyManager Reveal for Clinical Trial Management
StudyManager announced that Lehigh Valley Health Network selected StudyManager’s Reveal software to manage its clinical trials.
As a health network that includes three hospital facilities, nine health centers, and numerous primary and specialty care physician practices located throughout the state of Pennsylvania, Lehigh Valley Health Network sought a solution to centralize activity across multiple facilities and departments. Billing and protocol compliance, financial accountability, patient tracking, and high-level reporting for management oversight were all important criteria in selecting a CTMS system. Following an in-depth review process, Lehigh Valley selected StudyManager Reveal.
“We sought a CTMS that would centralize and organize our research operations to replace numerous manual and fragmented methods of capturing and recording data across our many research departments,” said Eric Mueller, MSA, Director of Research Administration, Lehigh Valley Health Network. “After evaluating several CTMS systems, we felt that StudyManager Reveal provided us the standardization needed, as well as the reporting capabilities to meet our compliance, study and patient tracking, and financial requirements.”
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
FDA-Approved Gene Therapy Beqvez Shows Sustained Efficacy, Safety in Long-Term Hemophilia B Trial
April 17th 2025Beqvez (fidanacogene elaparvovec), an FDA-approved one-time gene therapy for hemophilia B, demonstrated sustained factor IX expression, low bleeding rates, and a favorable safety profile over long-term follow-up.
